These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2574729)

  • 21. Oral labetalol in the management of stable angina pectoris in normotensive patients.
    Upward JW; Akhras F; Jackson G
    Br Heart J; 1985 Jan; 53(1):53-7. PubMed ID: 3917674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of oral nisoldipine for stable angina pectoris. The Nisoldipine Multicenter Angina Study Group.
    Frishman WH; Heiman M
    Am J Cardiol; 1991 Oct; 68(10):1004-9. PubMed ID: 1927911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antianginal and anti-ischemic efficacy of immediate-release nisoldipine in chronic stable angina pectoris.
    Glasser SP; Bittar N; Labreche DG; Singh B; Katz R; Schulman P
    Am J Cardiol; 1994 Jun; 73(16):1165-8. PubMed ID: 7911271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study.
    Savonitto S; Ardissiono D; Egstrup K; Rasmussen K; Bae EA; Omland T; Schjelderup-Mathiesen PM; Marraccini P; Wahlqvist I; Merlini PA; Rehnqvist N
    J Am Coll Cardiol; 1996 Feb; 27(2):311-6. PubMed ID: 8557899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate.
    Thadani U; Maranda CR; Amsterdam E; Spaccavento L; Friedman RG; Chernoff R; Zellner S; Gorwit J; Hinderaker PH
    Ann Intern Med; 1994 Mar; 120(5):353-9. PubMed ID: 8093132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-anginal and anti-ischemic effects of the selective beta-blocker talinolol in patients with stable angina pectoris.
    Faulhaber HD; Weigmann I; Lang U; Weinsberg F; Terhaag B
    Int J Clin Pharmacol Ther; 2005 Feb; 43(2):63-70. PubMed ID: 15726874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-response evaluation of once-daily therapy with a new formulation of diltiazem for stable angina pectoris. Diltiazem CD Study Group.
    Thadani U; Glasser S; Bittar N; Beach CL
    Am J Cardiol; 1994 Jul; 74(1):9-17. PubMed ID: 8017316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of bevantolol for chronic, stable angina pectoris.
    Bowles MJ; Khurmi NS; O'Hara MJ; Raftery EB
    Am J Cardiol; 1986 Nov; 58(12):28E-34E. PubMed ID: 2878598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of intermittent transdermal nitroglycerin on occurrence of ischemia after patch removal: results of the second transdermal intermittent dosing evaluation study (TIDES-II).
    Pepine CJ; Lopez LM; Bell DM; Handberg-Thurmond EM; Marks RG; McGorray S
    J Am Coll Cardiol; 1997 Oct; 30(4):955-61. PubMed ID: 9316524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of bevantolol and atenolol in chronic stable angina.
    Rodrigues EA; Lawrence JD; Dasgupta P; Hains AD; Lahiri A; Wilkinson PR; Raftery EB
    Am J Cardiol; 1988 Jun; 61(15):1204-9. PubMed ID: 2897780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of a metabolic modulator drug in chronic stable angina: review of evidence from clinical trials.
    Chaitman BR
    J Cardiovasc Pharmacol Ther; 2004 Sep; 9 Suppl 1():S47-64. PubMed ID: 15378131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 6-week double-blind comparison of amlodipine and placebo in patients with stable exertional angina pectoris receiving concomitant beta-blocker therapy.
    Klein W; Mitrovic V; Neuss H; Schlepper M; Cocco G; Prager G; Fitscha P; Meisner W
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S50-2. PubMed ID: 16296710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial.
    Borer JS; Fox K; Jaillon P; Lerebours G;
    Circulation; 2003 Feb; 107(6):817-23. PubMed ID: 12591750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical safety and efficacy of once-a-day amlodipine for chronic stable angina pectoris.
    Glasser SP; West TW
    Am J Cardiol; 1988 Sep; 62(9):518-22. PubMed ID: 2970788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical aspects of silent myocardial ischemia in patients with angina and other forms of coronary heart disease.
    Pepine CJ
    Am J Med; 1986 Apr; 80(4C):25-34. PubMed ID: 2871755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of PY 108-068, a new calcium channel blocker, for angina pectoris.
    de Buitleir M; Krikler S; Krikler DM
    Am J Cardiol; 1986 Jan; 57(1):15-9. PubMed ID: 3079940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
    Ruzyllo W; Tendera M; Ford I; Fox KM
    Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A dose-ranging, placebo-controlled, double-blind trial of nisoldipine in effort angina: duration and extent of antianginal effects.
    Lam J; Chaitman BR; Crean P; Blum R; Waters DD
    J Am Coll Cardiol; 1985 Aug; 6(2):447-52. PubMed ID: 3894474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study. The Zatebradine Study Group.
    Frishman WH; Pepine CJ; Weiss RJ; Baiker WM
    J Am Coll Cardiol; 1995 Aug; 26(2):305-12. PubMed ID: 7608428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dipyridamole in chronic stable angina pectoris; a randomized, double blind, placebo-controlled, parallel group study.
    Picano E;
    Eur Heart J; 2001 Oct; 22(19):1785-93. PubMed ID: 11549300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.